Ozempic vs Wegovy: Same Drug, Different Doses — What You Need to Know
Ozempic and Wegovy are both semaglutide. Learn the key differences in dosing, FDA approval, insurance coverage, and which one is prescribed for weight loss.
| Dimension | semaglutide | semaglutide | Notes |
|---|---|---|---|
| Active Ingredient | Semaglutide | Semaglutide | Identical molecule. The difference is dose, indication, and branding. |
| FDA Indication | Type 2 Diabetes | Chronic Weight Management | Ozempic approved for T2D. Wegovy approved for obesity/overweight with comorbidity. |
| Max Dose | 2.0 mg/week | 2.4 mg/week | Wegovy goes to a higher maintenance dose specifically optimized for weight loss. |
| Insurance | Better T2D coverage | Weight loss coverage varies | Ozempic often easier to get covered for diabetes. Wegovy coverage for obesity improving but inconsistent. |
| Off-Label Use | Common for weight loss | N/A (on-label) | Many get Ozempic prescribed off-label for weight loss due to better insurance coverage. |
Learn more about each peptide
Semaglutide
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight loss effects in clinical trials. It is sold under the brand names Ozempic (diabetes) and Wegovy (weight management).
Semaglutide
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight loss effects in clinical trials. It is sold under the brand names Ozempic (diabetes) and Wegovy (weight management).
More comparisons
Weekly peptide research updates
New studies, GLP-1 news, protocol insights, and weight loss data — delivered every week. Free. No spam.
Reviewed by Fat Man in the Arena · Updated March 2026
Medical Disclaimer: This comparison is for informational purposes only. Individual responses vary. Always consult a qualified healthcare provider before starting any peptide protocol.